Updated: House panel: Mylan CEO minimized EpiPen profits in testimony

WASHINGTON — Leaders of the House Oversight Committee want EpiPen maker Mylan to explain why the company’s CEO apparently misled Congress about profits the company claimed for the life-saving EpiPen injection device. Mylan CEO Heather Bresch repeatedly told the panel last month that Mylan made just $50 in profit for EpiPens sold for more than […]